{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T13:01:50Z","timestamp":1786798910292,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.drugalcdep.2014.07.009","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T03:30:19Z","timestamp":1405567819000},"page":"268-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates"],"prefix":"10.1016","volume":"143","author":[{"given":"Erin E.","family":"Bonar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisham","family":"Ashrafioun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Ilgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0005","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1465-3362.2012.00519.x","article-title":"Patterns of synthetic cannabinoid use in Australia","volume":"32","author":"Barratt","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0010","series-title":"Cognitive Therapy of Substance Abuse","author":"Beck","year":"1993"},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jen.2011.01.006","article-title":"Synthetic cannabinoids","volume":"37","author":"Camp","year":"2011","journal-title":"J. Emerg. Nurs."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0020","unstructured":"Centers for Disease Control and Prevention, 2013a. Acute Kidney Injury Associated with Synthetic Cannabinoid Use\u2014Multiple States, 2012. MMWR, pp. 93\u201398."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0025","unstructured":"Centers for Disease Control and Prevention, 2013b. Notes from the Field: Severe Illness Associated with Reported Use of Synthetic Marijuana\u2014Colorado, August\u2013September 2013. MMWR 62, 1016\u20131017."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0030","unstructured":"Department of Justice, D.E.A., 2013. Schedules of Controlled Substances: Temporary Placement of Three Synthetic Cannabinoids into Schedule I. Federal Register 78, pp. 28735\u201328739."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1017\/S0033291700048017","article-title":"The brief symptom inventory: an introductory report","volume":"13","author":"Derogatis","year":"1983","journal-title":"Psychol. Med."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0040","series-title":"The Brief Symptom Inventory (Bsi): Administration, Scoring, and Procedures Manual-1","author":"Derogatis","year":"1982"},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lfs.2013.09.017","article-title":"Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Delta-THC: mechanism underlying greater toxicity?","volume":"97","author":"Fantegrossi","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0050","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1177\/0960327111421945","article-title":"Synthetic cannabinoid and marijuana exposures reported to poison centers","volume":"31","author":"Forrester","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1747-597X-6-16","article-title":"College students and use of K2: an emerging drug of abuse in young persons","volume":"6","author":"Hu","year":"2011","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/dta.268","article-title":"The emergence and analysis of synthetic cannabinoids","volume":"3","author":"Hudson","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0065","series-title":"Core Data Codebook","article-title":"Monitoring the future: a continuing study of american youth (12th-grade survey), 2010","author":"Johnston","year":"2010"},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0075","series-title":"Overview, Key Findings on Adolescent Drug Use","article-title":"Monitoring the future national results on drug use: 1975\u20132013","author":"Johnston","year":"2014"},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drugpo.2009.09.001","article-title":"Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies","volume":"21","author":"McLaren","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005053-198001000-00006","article-title":"An improved diagnostic evaluation instrument for substance abuse patients","volume":"168","author":"McLellan","year":"1980","journal-title":"Addict. Severity Index. J. Nerv. Ment. Dis."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pnpbp.2012.04.017","article-title":"Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids","volume":"39","author":"Seely","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.drugalcdep.2011.07.011","article-title":"A survey study to characterize use of spice products (synthetic cannabinoids)","volume":"120","author":"Vandrey","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0105","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.toxlet.2010.06.002","article-title":"Spice drugs as a new trend: mode of action, identification and legislation","volume":"197","author":"Vardakou","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0110","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1345\/aph.1P580","article-title":"The \u201cnew\u201d marijuana","volume":"45","author":"Wells","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0115","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2012.12.011","article-title":"Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample","volume":"131","author":"Winstock","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.07.009_bib0120","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpeds.2012.12.056","article-title":"Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States","volume":"163","author":"Wood","year":"2013","journal-title":"J. Pediatr."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614009806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614009806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T14:53:18Z","timestamp":1538405598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614009806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":22,"alternative-id":["S0376871614009806"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.07.009","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}